Secukinumab in ankylosing spondylitis or psoriatic arthritis: Added benefit not proven

(Institute for Quality and Efficiency in Health Care) Drug manufacturer presented no relevant data and claimed no added benefit. Notable was the non-publication of literature searches and analyses.